Diffuse Large B Cell Lymphoma Relapsed Clinical Trials

6 clinical trials for Diffuse Large B Cell Lymphoma Relapsed across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — RECRUITING · PHASE3
• A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL) — RECRUITING · PHASE1
• Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies — RECRUITING · PHASE1
• Immunotherapy in Lymphoma — RECRUITING
• Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma — COMPLETED · PHASE1

Refine this search